Page 52 - MemoriaER-Eng

TRANSVERSAL PLATFORMS

Objective 2: To promote a Strategic Alliance and Dissemination Plan

• Affiliation and collaboration with national and international biobank net-
works

CIBERER Biobank:

• continued collaborating with the Biobank Network of Valencia in which it is inte-

grated;

• signed a Specific Collaboration Agreement with the Public Health Research Centre

for locating the Biobank in said centre’s facilities;

• signed an Agreement (July 2012) with Sistemas Genómicos that is still in force to

send samples of RD to the CIBERER Biobank from clinics of Sistemas Genómicos;

• participated in the Work Group of Blood Derivatives of the National Biobank Net-
work;

• participated as an ‘Associated Partner’ in a 7PM project (HEALTH.2012.2.1.11-C:

databases, biobanks and clinical bio-informatics hub for rare diseases) coordi-

nated byH. Lochmüller, of Newcastle University;

• Disseminating information about Biobank activity

The biobank participated in six conference/meetings in 2013, dissemination informa-

tion about its activities (RD-Connect kick off meeting; 6th Annual CIBERER Meeting;
2nd TREAT-CMT Scientific Meeting; presentation of the Biobank in the International í

Conference on Glycogen Storage Disease in Barcelona; BBMRI Conference; Annual
Meeting of the National Biobank Network).

ó
é
Objective 3: To generate added value for CIBERER groups

CIBERER groups value the importance of having the Biobank platform within the net-
work. In 2013 several expressions of interest in collaborating with the Biobank were

submitted by CIBERER groups, including:
é

í
ó
• Group: U704. Dra. Ayuso / Dra. Marta Cortón.- Collaboration in immortal-
izing cell lines.

é
• Group: U730. Dr. Nunes/Dr. Miguel Lpez de Heredia.- In the framework
of an international project (European and North American groups) to study Wolf-
í
ram syndrome, samples of DNA, RNA and immortalized cell lines will be collected
(from about 30 patients). CIBERER Biobank will handle processing, storing and í

safeguarding these samples.
13
• Group: U733. Dr. Pallard/Dr. Jos Luis Garca.- The Biobank collects and 20
T
manages samples for two projects led by these investigators.
R
PO
• Group: U745. Dr. J. Surralls/Dr. Mara Jos Ramrez.- Collaboration in im- E
L R
mortalizing cell lines of patients with Fanconi anemia.
A
NU
• Group: U753. Dr. Pablo Lapunzina.- Collaboration in immortalizing cell lines of N
patients with different pathologies.
A
/
ER
• Group: U760 Dr. Vctor L. Ruiz.- Collaboration in immortalizing cell lines of ER
patients with different pathologies.
B
CI

52